TD

Translational Development Acquisition Corp.

TDACFinancial ServicesNASDAQ

Shell Companies · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$0
Net Income
$6.4M
+9059.7% YoY
EBITDA
-$944,538
-381.0% YoY
Free Cash Flow
-$355,048

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▲ Above MA150+0.7% from MA150, price crossed above
Oct 19▲ Above MA150+0.8% from MA150, price crossed above
About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. operates in the Shell Companies space. Translational Development Acquisition Corp. The $208.7M market capitalization puts TDAC squarely in micro-cap range for its industry. does not have significant operations.

Where TDAC stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, TDAC finished 0.65% above its 150-day moving average ($10.74) and 1.22% above its 200-day moving average ($10.68). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is TDAC overbought or oversold?

At the October 20, 2026 close, TDAC's RSI(14) was 36.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$208.7M
P/E (TTM)41.58
EPS$0.26
52W Change+3.6%
Dividend Yield0.00%
Analysis

The company holds $86K in cash, though total debt stands at $1.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$355K. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Translational Development Acquisition Corp.'s trajectory.

Links
More Financial Services stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms